Hello @linda7 thank you for adding that, indeed it seems that along with being "perceived as safer" it is odd there is no comment about cost or financial burden of biologicals ! Here is a section of the abstract :
I've decided to comment to her LINKED in post and ask why did her team choose PMR and GCA among the zillions of other diseases : ) ! I know that Novartis has/had a clinical trial for PMR.

" Sentiment of pts around various treatments (n=297) available for PMR and GCA was negative (61%), mostly driven by side effects/intolerability, inefficacy/waning efficacy and flare-ups during steroid tapering. From the overall responses related to treatment perceptions (n=41), glucocorticoids (GC) had a relatively negative perception (35%), whereas biologics had a more positive perception (27%) and were perceived as a safer alternative by pts."